Leonel Torrão

446 total citations
17 papers, 377 citations indexed

About

Leonel Torrão is a scholar working on Neurology, Pharmacology and Psychiatry and Mental health. According to data from OpenAlex, Leonel Torrão has authored 17 papers receiving a total of 377 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Neurology, 6 papers in Pharmacology and 5 papers in Psychiatry and Mental health. Recurrent topics in Leonel Torrão's work include Parkinson's Disease Mechanisms and Treatments (7 papers), Attention Deficit Hyperactivity Disorder (3 papers) and Drug Transport and Resistance Mechanisms (2 papers). Leonel Torrão is often cited by papers focused on Parkinson's Disease Mechanisms and Treatments (7 papers), Attention Deficit Hyperactivity Disorder (3 papers) and Drug Transport and Resistance Mechanisms (2 papers). Leonel Torrão collaborates with scholars based in Portugal, Switzerland and United States. Leonel Torrão's co-authors include Maria João Bonifácio, Patrício Soares‐da‐Silva, P. Nuno Palma, Lyndon Wright, David A. Learmonth, Humberto Ferreira, László E. Kiss, Ilda Abreu, Sı́lvia Coimbra and Ana I. Loureiro and has published in prestigious journals such as The FASEB Journal, Journal of Medicinal Chemistry and British Journal of Pharmacology.

In The Last Decade

Leonel Torrão

17 papers receiving 371 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Leonel Torrão Portugal 10 138 103 67 63 53 17 377
Anna Furgała Poland 12 36 0.3× 84 0.8× 30 0.4× 90 1.4× 76 1.4× 23 377
Ko‐ichi Ohtaki Japan 7 113 0.8× 106 1.0× 9 0.1× 45 0.7× 130 2.5× 24 316
Chad M. VanDenBerg United States 11 44 0.3× 88 0.9× 56 0.8× 20 0.3× 49 0.9× 19 359
Eiichi Nakajima Japan 10 80 0.6× 115 1.1× 26 0.4× 15 0.2× 50 0.9× 48 356
Klaus Klinder Germany 13 61 0.4× 143 1.4× 25 0.4× 29 0.5× 89 1.7× 15 419
A. von Hodenberg Germany 10 29 0.2× 193 1.9× 141 2.1× 84 1.3× 98 1.8× 17 636
Etsuko Usuki United States 10 48 0.3× 115 1.1× 98 1.5× 29 0.5× 102 1.9× 14 429
Łukasz Fijałkowski Poland 10 14 0.1× 108 1.0× 16 0.2× 46 0.7× 53 1.0× 20 377
Kai Lamottke Germany 8 12 0.1× 181 1.8× 39 0.6× 184 2.9× 45 0.8× 11 478
Alice Kunzler Brazil 14 46 0.3× 123 1.2× 6 0.1× 75 1.2× 28 0.5× 20 363

Countries citing papers authored by Leonel Torrão

Since Specialization
Citations

This map shows the geographic impact of Leonel Torrão's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Leonel Torrão with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Leonel Torrão more than expected).

Fields of papers citing papers by Leonel Torrão

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Leonel Torrão. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Leonel Torrão. The network helps show where Leonel Torrão may publish in the future.

Co-authorship network of co-authors of Leonel Torrão

This figure shows the co-authorship network connecting the top 25 collaborators of Leonel Torrão. A scholar is included among the top collaborators of Leonel Torrão based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Leonel Torrão. Leonel Torrão is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

17 of 17 papers shown
1.
Chen, Jin, Jessie Gu, Rowan Stringer, et al.. (2021). Pharmacokinetics of Tropifexor, a Potent Farnesoid X Receptor Agonist, in Participants With Varying Degrees of Hepatic Impairment. The Journal of Clinical Pharmacology. 62(4). 520–531. 1 indexed citations
2.
Murgasova, Renata, et al.. (2020). Non‐clinical characterization of the disposition of EMA401, a novel small molecule angiotensin II type 2 receptor (AT2R) antagonist. Biopharmaceutics & Drug Disposition. 41(4-5). 166–183. 5 indexed citations
3.
Isbell, John, et al.. (2018). Plasma Protein Binding of Highly Bound Drugs Determined With Equilibrium Gel Filtration of Nonradiolabeled Compounds and LC-MS/MS Detection. Journal of Pharmaceutical Sciences. 108(2). 1053–1060. 20 indexed citations
4.
Ferreira, Humberto, David A. Learmonth, Maria João Bonifácio, et al.. (2016). Synthesis and structure–activity relationships of ionizable 1,3,4-oxadiazol-2(3H)-ones as peripherally selective FAAH inhibitors with improved aqueous solubility. Pure and Applied Chemistry. 88(4). 341–347. 3 indexed citations
5.
Bonifácio, Maria João, Leonel Torrão, Ana I. Loureiro, et al.. (2014). Pharmacological profile of opicapone, a third‐generation nitrocatechol catechol‐O‐methyl transferase inhibitor, in the rat. British Journal of Pharmacology. 172(7). 1739–1752. 48 indexed citations
6.
7.
Bonifácio, Maria João, Leonel Torrão, Ana Loureiro, Lyndon Wright, & Patrício Soares‐da‐Silva. (2011). 2.243 OPICAPONE: CHARACTERIZATION OF A NOVEL PERIPHERAL LONG-ACTING CATECHOL-O-METHYLTRANSFERASE INHIBITOR. Parkinsonism & Related Disorders. 18. S125–S125. 10 indexed citations
8.
Bonifácio, Maria João, et al.. (2011). 2.242 BRAIN AND PERIPHERAL LEVODOPA PHARMACOKINETICS IN THE CYNOMOLGUS MONKEY FOLLOWING ADMINISTRATION OF OPICAPONE, A NOVEL CATECHOL-O-METHYLTRANSFERASE INHIBITOR. Parkinsonism & Related Disorders. 18. S125–S125. 7 indexed citations
9.
Kiss, László E., et al.. (2011). Design, synthesis, and structure–activity relationships of 1,3,4-oxadiazol-2(3H)-ones as novel FAAH inhibitors. MedChemComm. 2(9). 889–889. 19 indexed citations
10.
Almeida, Luís, Ana I. Loureiro, Manuel Vaz‐da‐Silva, et al.. (2010). Chronopharmacology of nebicapone, a new catechol- O -methyltransferase inhibitor. Current Medical Research and Opinion. 26(5). 1097–1108. 3 indexed citations
11.
Kiss, László E., Humberto Ferreira, Leonel Torrão, et al.. (2010). Discovery of a Long-Acting, Peripherally Selective Inhibitor of Catechol-O-methyltransferase. Journal of Medicinal Chemistry. 53(8). 3396–3411. 138 indexed citations
12.
13.
Bonifácio, Maria João, Ana I. Loureiro, Leonel Torrão, et al.. (2009). Species differences in pharmacokinetic and pharmacodynamic properties of nebicapone. Biochemical Pharmacology. 78(8). 1043–1051. 10 indexed citations
14.
Vaz‐da‐Silva, Manuel, Ana I. Loureiro, Teresa Nunes, et al.. (2008). Pharmacokinetic-Pharmacodynamic Interaction between Nebicapone, a Novel Catechol-O-Methyltransferase Inhibitor, and Controlled-Release Levodopa/Carbidopa 200 mg/50 mg. Drugs in R&D. 9(6). 435–446. 4 indexed citations
15.
Bonifácio, Maria João, Leonel Torrão, Lyndon Wright, & Patrício Soares‐da‐Silva. (2007). Membrane‐bound COMT inhibition by Nebicapone. The FASEB Journal. 21(6). 1 indexed citations
16.
Almeida, Luís, Manuel Vaz‐da‐Silva, Amílcar Falcão, et al.. (2004). Pharmacokinetic–Pharmacodynamic Interaction Between BIA 3-202, a Novel COMT Inhibitor, and Levodopa/Carbidopa. Clinical Neuropharmacology. 27(1). 17–24. 14 indexed citations
17.
Coimbra, Sı́lvia, Leonel Torrão, & Ilda Abreu. (2004). Programmed cell death induces male sterility in Actinidia deliciosa female flowers. Plant Physiology and Biochemistry. 42(6). 537–541. 46 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Anna Furgała Breakdown of academic impact, for papers by Ko‐ichi Ohtaki Breakdown of academic impact, for papers by Chad M. VanDenBerg Breakdown of academic impact, for papers by Eiichi Nakajima Breakdown of academic impact, for papers by Klaus Klinder Breakdown of academic impact, for papers by A. von Hodenberg Breakdown of academic impact, for papers by Etsuko Usuki Breakdown of academic impact, for papers by Łukasz Fijałkowski Breakdown of academic impact, for papers by Kai Lamottke Breakdown of academic impact, for papers by Alice Kunzler
Rankless by CCL
2026